President of Ohio radiology company indicted on $2M x-ray billing scheme

Matt O'Connor | | Health Imaging | Economics

The president of Portable Radiology Services in North Canton, Ohio has been indicted for defrauding Medicare and Medicaid of nearly $2 million for billing x-ray services that were never rendered, reported Cleveland 19 News.

Thomas G. O’Lear, 55, has been charged with 25 counts of healthcare fraud and one count of false statements for his company’s billing scheme that went on from January 2013 through December 2017, according to 19 News. That included more than 150 instances in which Portable Radiology Services claimed to have provided x-rays to patients who were already deceased.

North Canton man indicted for defrauding Medicare and Medicaid out $2 million

According to the report, O’Lear sought to cover up the fraud by forging signatures of medical professionals to make it seem the x-rays had been administered to patients.

Portable Radiology Services provided portable x-ray services to patients in nursing homes and other care facilities.

Read the entire story below.

""
Matt O'Connor

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Related Content

Building a successful CCTA program: Physicians and healthcare executives to share advice
Shift toward imaging outside the hospital could save billions
Mexico, not China, is biggest tariff concern among radiology vendors
The impact of Trump tariffs on iodine contrast media costs
The biggest obstacles facing radiology business managers in 2025
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.